• Latest
  • Trending
Novo Nordisk, Aspen to expand Insulin production in Africa

Novo Nordisk, Aspen to expand Insulin production in Africa

September 29, 2023
Call of Duty movie: Paramount, Activision strike deal for live-action adaptation

Call of Duty movie: Paramount, Activision strike deal for live-action adaptation

September 5, 2025
Meta Brings Back Facebook Poke with Emojis and Streaks

Meta Brings Back Facebook Poke with Emojis and Streaks

September 5, 2025
Know why they’re calling: Truecaller launches AI-powered insights

Know why they’re calling: Truecaller launches AI-powered insights

September 5, 2025
Visa harnesses local partnerships to launch Visa Pay in DR Congo

Visa harnesses local partnerships to launch Visa Pay in DR Congo

September 5, 2025
Betika denies recent reports of security breach

Betika denies recent reports of security breach

September 5, 2025
10 things you can actually buy with crypto in Africa

10 things you can actually buy with crypto in Africa

September 5, 2025
CBE seals deal with Botim to enhance remittance services for Ethiopians living in UAE

CBE seals deal with Botim to enhance remittance services for Ethiopians living in UAE

September 5, 2025
Nigeria Senate, SIBAN push for crypto regulation to boost digital economy

Nigeria Senate, SIBAN push for crypto regulation to boost digital economy

September 5, 2025
Mamo Mihretu Resigns as Governor of Ethiopia’s Central Bank

Mamo Mihretu Resigns as Governor of Ethiopia’s Central Bank

September 5, 2025
Paratus Group introduces first private mobile network using LTE and 5G in Namibia

Paratus Group introduces first private mobile network using LTE and 5G in Namibia

September 5, 2025
Your one-stop tech hub! Get the latest updates on AI, cybersecurity, fintech, and emerging technologies.
  • Tech News
    • Africa Tech
    • Global Tech
    • Tech with Pelumy
    • Tech Careers
    • General News
    • How To
    • Reviews
  • Cryptocurrency
  • Fintech
  • Startups
  • Ai
No Result
View All Result
  • Tech News
    • Africa Tech
    • Global Tech
    • Tech with Pelumy
    • Tech Careers
    • General News
    • How To
    • Reviews
  • Cryptocurrency
  • Fintech
  • Startups
  • Ai
No Result
View All Result
Techpression
No Result
View All Result
Home Tech News Africa Tech News

Novo Nordisk, Aspen to expand Insulin production in Africa

Ibukunoluwa Bankole by Ibukunoluwa Bankole
September 29, 2023
149 1
0
Novo Nordisk, Aspen to expand Insulin production in Africa
465
SHARES
Share on FacebookShare on TwitterWhatsAppTelegram

In a pivotal agreement poised to transform diabetes care across sub-Saharan Africa, Danish pharmaceutical giant Novo Nordisk and South African generic drug manufacturer Aspen have embarked on a groundbreaking partnership. This collaboration not only aims to significantly enhance the supply of insulin in the region but also involves the transfer of production rights and technology to Aspen.

Read Also: Kenya launches smart Primary Care Network with 100,000 health promoters

Expanding Access to Insulin Across Sub-Saharan Africa

The cornerstone of this historic partnership revolves around augmenting the availability of insulin across sub-Saharan Africa. Novo Nordisk, a global leader in diabetes care, has taken a bold step to bolster its production capacity dramatically. By next year, it aims to provide insulin for an estimated 1.1 million individuals living with diabetes in sub-Saharan Africa.

This remarkable initiative more than doubles the current reach, which caters to the needs of approximately 500,000 people. By 2026, the collaborative efforts of Novo Nordisk and Aspen aspire to address the insulin requirements of an impressive 4.1 million diabetes patients across the African continent, spanning both type 1 and type 2 diabetes.

RelatedPosts

Arigo launches digital solutions to address specific life issues

Digital Realty names Marcel Louw as Managing Director for Africa

Nigerian blockchain leaders unite under SiBAN, propose $100 million fund for African projects

Crucially, this partnership embodies the principles of sustainability and equity. The agreement stipulates that Novo Nordisk commits to a minimum purchase obligation of €195.5 million from Aspen, spanning the period from 2024 to 2028. This substantial investment underscores Novo Nordisk’s unwavering commitment to ensuring access to essential diabetes treatments at an affordable cost. The initiative aligns seamlessly with Novo Nordisk’s sustainable business integrated model, known as iCARE. Through this model, Novo Nordisk is steadfastly dedicated to maintaining the maximum price of human insulin at a mere $3 per vial, making it accessible to a broader population.

Empowering Local Production and Supporting a Global Initiative

Beyond expanding access, this partnership holds great significance for the African Union’s Pharmaceutical Manufacturing Plan for Africa. By fostering local insulin production, storage, and distribution, the collaboration underscores the commitment to advancing healthcare on the African continent. This initiative heralds more equitable access to life-saving diabetes care, thereby aligning with global efforts to combat diabetes.

The announcement of this monumental partnership transpired during health-related discussions at the United Nations in New York. The World Health Organization (WHO), through its WHO Global Diabetes Compact, played an instrumental role in promoting this collaboration. Launched two years ago, the compact has been a driving force in advocating for increased insulin access globally.

WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized the urgent need for improved insulin access, particularly in low- and middle-income countries. Dr. Tedros highlighted the stark reality that half of those who require insulin for diabetes management currently lack access. In Africa alone, there are presently 24 million adults living with diabetes, and this number is projected to exceed 55 million by 2045. This partnership represents a significant stride towards addressing this critical healthcare challenge.

DRC startup Nuru secures $40 million to build mini-grid in sub-Saharan Africa

Enthusiastic Government Support and Prospects for Future Growth

The South African government has warmly welcomed this partnership, emphasizing its potential to not only enhance insulin production but also stimulate additional opportunities for licensing and manufacturing of essential medications. South Africa’s Minister of Trade and Industry, Ebrahim Patel, commended the agreement, highlighting its importance in enabling local production of human insulin. Moreover, he underscored the broader potential for the development and production of various crucial medications.

The insulin production process will capitalize on Aspen’s sterile infrastructure in Gqeberha, South Africa. Notably, this infrastructure previously played a role in Aspen’s endeavors related to COVID-19 vaccine production. This concerted effort reflects a shared commitment to delivering sustainable and quality healthcare to individuals across sub-Saharan Africa and beyond.

Tags: AfricaAspenInsulinNovo Nordisk
Ibukunoluwa Bankole

Ibukunoluwa Bankole

No Result
View All Result

Quick Links

  • Tech News
  • Cryptocurrency
  • Fintech
  • Startups
  • Business

Follow Us:

  • facebook
  • instagram
  • Twitter(X)
  • Linkedin
  • YouTube
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 Techpression.com -Techpression Media Limited

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

No Result
View All Result
  • Home
  • Tech News
    • Africa Tech
    • Global Tech
    • Tech with Pelumy
    • Tech Careers
    • Reviews
    • How To
    • General News
  • Cryptocurrency
  • Business
  • Fintech
  • Startups
  • Featured
  • Ai
  • Tech TV

© 2025 Techpression.com -Techpression Media Limited

techpression.com
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.